Nonmyristoylated Matrix Protein from the Mason-Pfizer Monkey Virus Forms Oligomers

Journal of Molecular Biology

Volumn 390, Issue 5, 2009, Pages 967-980

  Vlach, Jiří ^a   Srb, Pavel ^a,b   Prchal, Jan ^a   Grocký, Marián ^b   Lang, Jan ^b   Ruml, Tomáš ^a   Hrabal, Richard ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Mason Pfizer monkey virus; matrix protein; NMR; oligomerization; retrovirus

Indexed keywords

DIMER; MATRIX PROTEIN; MONOMER; MUTANT PROTEIN; OLIGOMER;

ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DISSOCIATION CONSTANT; MASON PFIZER MONKEY VIRUS; MYRISTYLATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE; RETROVIRUS;

MASON-PFIZER MONKEY VIRUS;

EID: 67649886954     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.05.063     Document Type: Article

References (58)

1. Rhee S.S., and Hunter E. Myristoylation is required for intracellular transport but not for assembly of D-type retrovirus capsids. J. Virol. 61 (1987) 1045-1053
2. Spearman P., Wang J.J., Heyden N.V., and Ratner L. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68 (1994) 3232-3242
3. Zhou W., Parent L.J., Wills J.W., and Resh M.D. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68 (1994) 2556-2569
4. Ono A., Ablan S.D., Lockett S.J., Nagashima K., and Freed E.O. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl Acad. Sci. USA 101 (2004) 14889-14894
5. Saad J.S., Miller J., Tai J., Kim A., Ghanam R.H., and Summers M.F. . Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl Acad. Sci. USA 103 (2006) 11364-11369
6. Murray P.S., Li Z., Wang J., Tang C.L., Honig B., and Murray D. Retroviral matrix domains share electrostatic homology: models for membrane binding function throughout the viral life cycle. Structure 13 (2005) 1521-1531
7. Conte M.R., and Matthews S. Retroviral matrix proteins: a structural perspective. Virology 246 (1998) 191-198
8. Hatanaka H., Iourin O., Rao Z., Fry E., Kingsman A., and Stuart D.I. Structure of equine infectious anemia virus matrix protein. J. Virol. 76 (2002) 1876-1883
9. Riffel N., Harlos K., Iourin O., Rao Z., Kingsman A., Stuart D., and Fry E. Atomic resolution structure of Moloney murine leukemia virus matrix protein and its relationship to other retroviral matrix proteins. Structure 10 (2002) 1627-1636
10. Rao Z., Belyaev A.S., Fry E., Roy P., Jones I.M., and Stuart D.I. Crystal structure of SIV matrix antigen and implications for virus assembly. Nature 378 (1995) 743-747
11. Hill C.P., Worthylake D., Bancroft D.P., Christensen A.M., and Sundquist W.I. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl Acad. Sci. USA 93 (1996) 3099-3104
12. Scarlata S., Ehrlich L.S., and Carter C.A. Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions. J. Mol. Biol. 277 (1998) 161-169
13. Morikawa Y., Zhang W.H., Hockley D.J., Nermut M.V., and Jones I.M. Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17. J. Virol. 72 (1998) 7659-7663
14. Morikawa Y., Hockley D.J., Nermut M.V., and Jones I.M. Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly. J. Virol. 74 (2000) 16-23
15. Massiah M.A., Starich M.R., Paschall C., Summers M.F., Christensen A.M., and Sundquist W.I. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J. Mol. Biol. 244 (1994) 198-223
16. Matthews S., Barlow P., Boyd J., Barton G., Russell R., Mills H., et al. Structural similarity between the p17 matrix protein of HIV-1 and interferon-gamma. Nature 370 (1994) 666-668
17. Tang C., Loeliger E., Luncsford P., Kinde I., Beckett D., and Summers M.F. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl Acad. Sci. USA 101 (2004) 517-522
18. Wu Z., Alexandratos J., Ericksen B., Lubkowski J., Gallo R.C., and Lu W. . Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation. Proc. Natl Acad. Sci. USA 101 (2004) 11587-11592
19. Saad J.S., Ablan S.D., Ghanam R.H., Kim A., Andrews K., Nagashima K., et al. Structure of the myristoylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting. J. Mol. Biol. 382 (2008) 434-447
20. Provitera P., Bouamr F., Murray D., Carter C., and Scarlata S. Binding of equine infectious anemia virus matrix protein to membrane bilayers involves multiple interactions. J. Mol. Biol. 296 (2000) 887-898
21. Chen K., Bachtiar I., Piszczek G., Bouamr F., Carter C., and Tjandra N. Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2. Biochemistry 47 (2008) 1928-1937
22. McDonnell J.M., Fushman D., Cahill S.M., Zhou W., Wolven A., Wilson C.B., et al. Solution structure and dynamics of the bioactive retroviral M domain from Rous sarcoma virus. J. Mol. Biol. 279 (1998) 921-928
23. Sfakianos J.N., LaCasse R.A., and Hunter E. The M-PMV cytoplasmic targeting-retention signal directs nascent Gag polypeptides to a pericentriolar region of the cell. Traffic 4 (2003) 660-670
24. Vlach J., Lipov J., Rumlová M., Veverka V., Lang J., Srb P., et al. D-retrovirus morphogenetic switch driven by the targeting signal accessibility to Tctex-1 of dynein. Proc. Natl Acad. Sci. USA 105 (2008) 10565-10570
25. Yasuda J., and Hunter E. Role of matrix protein in the type D retrovirus replication cycle: importance of the arginine residue at position 55. Virology 268 (2000) 533-538
26. Rhee S.S., and Hunter E. A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell 63 (1990) 77-86
27. Dominguez C., Boelens R., and Bonvin A.M.J.J. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 125 (2003) 1731-1737
28. de Vries S.J., van Dijk A.D.J., Krzeminski M., van Dijk M., Thureau A., Hsu V., et al. HADDOCK versus HADDOCK: new features and performance of HADDOCK2.0 on the CAPRI targets. Proteins 69 (2007) 726-733
29. Ferrage F., Zoonens M., Warschawski D., Popot J., and Bodenhausen G. Slow diffusion of macromolecular assemblies by a new pulsed field gradient NMR method. J. Am. Chem. Soc. 125 (2003) 2541-2545
30. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., et al. Clustal W and Clustal X version 2.0. Bioinformatics 23 (2007) 2947-2948
31. Clamp M., Cuff J., Searle S.M., and Barton G.J. The Jalview Java alignment editor. Bioinformatics 20 (2004) 426-427
32. Rumlova-Klikova M., Hunter E., Nermut M.V., Pichova I., and Ruml T. Analysis of Mason-Pfizer monkey virus Gag domains required for capsid assembly in bacteria: role of the N-terminal proline residue of CA in directing particle shape. J. Virol. 74 (2000) 8452-8459
33. Ulbrich P., Haubova S., Nermut M.V., Hunter E., Rumlova M., and Ruml T. Distinct roles for nucleic acid in in vitro assembly of purified Mason-Pfizer monkey virus CANC proteins. J. Virol. 80 (2006) 7089-7099
34. Borsetti A., Ohagen A., and Göttlinger H.G. The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly. J. Virol. 72 (1998) 9313-9317
35. Gross I., Hohenberg H., Wilk T., Wiegers K., Grättinger M., Müller B., et al. A conformational switch controlling HIV-1 morphogenesis. EMBO J. 19 (2000) 103-113
36. Campbell S., and Vogt V.M. In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles. J. Virol. 71 (1997) 4425-4435
37. Joshi S.M., and Vogt V.M. Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli. J. Virol. 74 (2000) 10260-10268
38. Sommerfelt M.A., Rhee S.S., and Hunter E. Importance of p12 protein in Mason-Pfizer monkey virus assembly and infectivity. J. Virol. 66 (1992) 7005-7011
39. Sakalian M., and Rapp N.D. Rescue of internal scaffold-deleted Mason-Pfizer monkey virus particle production by plasma membrane targeting. Virology 345 (2006) 317-327
40. Knejzlík Z., Smékalová Z., Ruml T., and Sakalian M. Multimerization of the p12 domain is necessary for Mason-Pfizer monkey virus Gag assembly in vitro. Virology 365 (2007) 260-270
41. Yasuda J., and Hunter E. A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release. J. Virol. 72 (1998) 4095-4103
42. Gottwein E., Bodem J., Müller B., Schmechel A., Zentgraf H., and Kräusslich H.-G. The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release. J. Virol. 77 (2003) 9474-9485
43. Bohl C.R., Brown S.M., and Weldon R.A. The pp24 phosphoprotein of Mason-Pfizer monkey virus contributes to viral genome packaging. Retrovirology 2 (2005) 68
44. Nermut M.V., Bron P., Thomas D., Rumlova M., Ruml T., and Hunter E. Molecular organization of Mason-Pfizer monkey virus capsids assembled from Gag polyprotein in Escherichia coli. J. Virol. 76 (2002) 4321-4330
45. Nermut M.V., Hockley D.J., Jowett J.B., Jones I.M., Garreau M., and Thomas D. Fullerene-like organization of HIV gag-protein shell in virus-like particles produced by recombinant baculovirus. Virology 198 (1994) 288-296
46. Lu M., Blacklow S.C., and Kim P.S. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2 (1995) 1075-1082
47. Zhu P., Liu J., Bess J., Chertova E., Lifson J.D., Grisé H., et al. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441 (2006) 847-852
48. Sfakianos J.N., and Hunter E. M-PMV capsid transport is mediated by Env/Gag interactions at the pericentriolar recycling endosome. Traffic 4 (2003) 671-680
49. 15N resonances of WT matrix protein and its R55F mutant from Mason-Pfizer monkey virus. J. Biomol. NMR 31 (2005) 381-382
50. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe-a multidimensional spectral processing system based on Unix pipes. J. Biomol. NMR 6 (1995) 277-293
51. Goddard, T. D. & Kneller, D. G., SPARKY 3, University of California, San Francisco.
52. Jerschow A., and Muller N. Convection compensation in gradient enhanced nuclear magnetic resonance spectroscopy. J. Magn. Reson. 132 (1998) 13-18
53. Stott K., Stonehouse J., Keeler J., Hwang T.L., and Shaka A.J. Excitation sculpting in high-resolution nuclear-magnetic-resonance spectroscopy-application to selective NOE experiments. J. Am. Chem. Soc. 117 (1995) 4199-4200
54. Balayssac S., Delsuc M.-A., Gilard V., Prigent Y., and Malet-Martino M. Two-dimensional DOSY experiment with excitation sculpting water suppression for the analysis of natural and biological media. J. Magn. Reson. 196 (2009) 78-83
55. Pons J.L., Malliavin T.E., and Delsuc M.A. Gifa V 4: a complete package for NMR data set processing. J. Biomol. NMR 8 (1996) 445-452
56. Hubbard S.J., and Thornton J.M. NACCESS Computer Program (1993), Department of Biochemistry and Molecular Biology, University College London, London
57. de la Torre J.G., Huertas M.L., and Carrasco B. HydroNMR: prediction of NMR relaxation of globular proteins from atomic-level structures and hydrodynamic calculations. J. Magn. Reson. 147 (2000) 138-146
58. Schumann F.H., Riepl H., Maurer T., Gronwald W., Neidig K.-P., and Kalbitzer H.R. Combined chemical shift changes and amino acid specific chemical shift mapping of protein-protein interactions. J. Biomol. NMR 39 (2007) 275-289